Chinese AI-based drug maker Xbiome bags nearly $100m in Series B round

Chinese AI-based drug maker Xbiome bags nearly $100m in Series B round

Source: Volodymyr Hryshchenko/Unsplash

Xbiome, a Chinese drug development platform that utilises AI, has pocketed nearly $100 million in a Series B round. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter